Combination of ranibizumab and indomethacin for neovascular age-related macular degeneration: randomized controlled trial
Andrea Russo,1 Nicolò Scaroni,1 Elena Gambicorti,1 Raffaele Turano,1 Francesco Morescalchi,1 Ciro Costagliola,2 Francesco Semeraro1 1Eye Clinic, Department of Neurological and Vision Sciences, University of Brescia, Brescia, 2Eye Clinic, Department of Health Sciences, University of Molis...
Enregistré dans:
Auteurs principaux: | Russo A, Scaroni N, Gambicorti E, Turano R, Morescalchi F, Costagliola C, Semeraro F |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/518ce34b357b4dd59c15b9b40bbc3471 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
par: Karagiannis D, et autres
Publié: (2017) -
Real-World Effectiveness, Treatment Pattern, and Safety of Ranibizumab in Korean Patients with Neovascular Age-Related Macular Degeneration: Subgroup Analyses from the LUMINOUS Study
par: Sagong M, et autres
Publié: (2021) -
Ranibizumab in neovascular age-related macular degeneration: a 5-year follow-up
par: Cvetkova NP, et autres
Publié: (2016) -
One-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvement
par: Hirakata T, et autres
Publié: (2016) -
ANTI-ANGIOGENIC THERAPY IN PATIENTS WITH PATHOLOGIC MYOPIA AND CHOROIDAL NEOVASCULARIZATION
par: S. A. Korotkikh, et autres
Publié: (2016)